Kleanthis G. Xanthopoulos, Ph.D.
- Former Founding CEO of Regulus Therapeutics (NASDAQ:RGLS)
- Founder and Director of Sente Inc.
- Managing Director at Enterprise Partners, Venture Capital
- Former Founder and CEO at Anadys Pharma acquired by Roche for $230M
- M.Sc. Ph.D. in Molecular Biology from Stockholm
- Associate Professor of Karolinska Institute, Stockholm, Sweden